[PDF][PDF] Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma
F Mendrzyk, B Radlwimmer, S Joos… - Journal of clinical …, 2005 - Citeseer
Journal of clinical oncology, 2005•Citeseer
Purpose Medulloblastoma is the most common malignant brain tumor in children. Despite
multimodal aggressive treatment, nearly half of the patients die as a result of this tumor.
Identification of molecular markers for prognosis and development of novel pathogenesis-
based therapies depends crucially on a better understanding of medulloblastoma
pathomechanisms.
multimodal aggressive treatment, nearly half of the patients die as a result of this tumor.
Identification of molecular markers for prognosis and development of novel pathogenesis-
based therapies depends crucially on a better understanding of medulloblastoma
pathomechanisms.
Purpose
Medulloblastoma is the most common malignant brain tumor in children. Despite multimodal aggressive treatment, nearly half of the patients die as a result of this tumor. Identification of molecular markers for prognosis and development of novel pathogenesis-based therapies depends crucially on a better understanding of medulloblastoma pathomechanisms.
Citeseer